Published in Graefes Arch Clin Exp Ophthalmol on July 17, 2003
Effect of age and other factors on macular pigment optical density measured with resonance Raman spectroscopy. Graefes Arch Clin Exp Ophthalmol (2014) 1.99
Macular pigment optical density measurement in autofluorescence imaging: comparison of one- and two-wavelength methods. Graefes Arch Clin Exp Ophthalmol (2006) 1.68
Nonmydriatic fluorescence-based quantitative imaging of human macular pigment distributions. J Opt Soc Am A Opt Image Sci Vis (2006) 1.18
Measuring macular pigment optical density in vivo: a review of techniques. Graefes Arch Clin Exp Ophthalmol (2011) 1.12
Macular pigment, photopigments, and melanin: distributions in young subjects determined by four-wavelength reflectometry. Vision Res (2007) 0.98
The heritability of macular response to supplemental lutein and zeaxanthin: a classic twin study. Invest Ophthalmol Vis Sci (2012) 0.89
Macular pigment density in age-related maculopathy. Graefes Arch Clin Exp Ophthalmol (2004) 0.86
[The macular pigment: short- and intermediate-term changes of macular pigment optical density following supplementation with lutein and zeaxanthin and co-antioxidants. The LUNA Study]. Ophthalmologe (2009) 0.81
Macular pigment density at the site of altered fundus autofluorescence. Graefes Arch Clin Exp Ophthalmol (2010) 0.79
The heritability of the ring-like distribution of macular pigment assessed in a twin study. Invest Ophthalmol Vis Sci (2014) 0.79
Clinical applications of fundus autofluorescence in retinal disease. Int J Retina Vitreous (2016) 0.78
Association of age and macular pigment optical density using dual-wavelength autofluorescence imaging. Clin Ophthalmol (2013) 0.78
[cSLO digital fundus autofluorescence imaging]. Ophthalmologe (2005) 0.77
[Seasonal fluctuations and influence of nutrition on macular pigment density]. Ophthalmologe (2006) 0.75
Macular pigment in retinal health and disease. Int J Retina Vitreous (2016) 0.75
Individual Colorimetric Observer Model. PLoS One (2016) 0.75
Comparison of macular pigment optical density in patients with dry and wet age-related macular degeneration. Indian J Ophthalmol (2017) 0.75
An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol (1995) 10.05
Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Arch Ophthalmol (1999) 8.92
Pathophysiology of age-related macular degeneration. Surv Ophthalmol (1987) 3.17
Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group. Arch Ophthalmol (1992) 2.71
Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr (1995) 2.21
Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys (2001) 2.18
Analysis of the macular pigment by HPLC: retinal distribution and age study. Invest Ophthalmol Vis Sci (1988) 1.96
Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol (2001) 1.88
Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci (2001) 1.70
Stereochemistry of the human macular carotenoids. Invest Ophthalmol Vis Sci (1993) 1.68
The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci (1984) 1.60
A practical method for measuring macular pigment optical density. Invest Ophthalmol Vis Sci (1999) 1.55
The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol (1989) 1.53
Macular pigment and age related macular degeneration. Br J Ophthalmol (1999) 1.39
Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci (2000) 1.34
The macular pigment: a possible role in protection from age-related macular degeneration. Adv Pharmacol (1997) 1.25
The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology (1997) 1.21
Preventative ophthalmology. Age-related macular degeneration. Ophthalmology (1995) 1.08
Macular pigment optical density in a Southwestern sample. Invest Ophthalmol Vis Sci (2000) 1.08
Macular pigment and melanin in age-related maculopathy in a general population. Invest Ophthalmol Vis Sci (2002) 1.07
Raman detection of macular carotenoid pigments in intact human retina. Invest Ophthalmol Vis Sci (1998) 1.03
Age-related macular degeneration and antioxidant status in the POLA study. POLA Study Group. Pathologies Oculaires Liées à l'Age. Arch Ophthalmol (1999) 1.02
Distribution of individual macular pigment carotenoids in central retina of macaque and squirrel monkeys. Invest Ophthalmol Vis Sci (1991) 0.99
A new instrument for the quantification of macular pigment density: first results in patients with AMD and healthy subjects. Graefes Arch Clin Exp Ophthalmol (2002) 0.99
[Age-related macular degeneration. 2. Therapeutic approaches]. Ophthalmologe (1996) 0.75
Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care (2010) 3.29
Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Invest Ophthalmol Vis Sci (2009) 3.19
Classification of fundus autofluorescence patterns in early age-related macular disease. Invest Ophthalmol Vis Sci (2005) 1.76
Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol (2006) 1.72
TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES: A Literature Review and Consensus Recommendations. Retina (2015) 1.67
Differential targeting of GSH1 and GSH2 is achieved by multiple transcription initiation: implications for the compartmentation of glutathione biosynthesis in the Brassicaceae. Plant J (2005) 1.57
Quantitative analysis of fluorescence lifetime measurements of the macula using the fluorescence lifetime imaging ophthalmoscope in healthy subjects. Invest Ophthalmol Vis Sci (2014) 1.46
Morphologic changes in patients with geographic atrophy assessed with a novel spectral OCT-SLO combination. Invest Ophthalmol Vis Sci (2008) 1.42
Elaborate spatial patterning of cell-wall PME and PMEI at the pollen tube tip involves PMEI endocytosis, and reflects the distribution of esterified and de-esterified pectins. Plant J (2007) 1.34
Correlation between the area of increased autofluorescence surrounding geographic atrophy and disease progression in patients with AMD. Invest Ophthalmol Vis Sci (2006) 1.34
Structural insights into the target specificity of plant invertase and pectin methylesterase inhibitory proteins. Plant Cell (2004) 1.33
Microcystic macular degeneration from optic neuropathy. Brain (2012) 1.27
Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results. Ophthalmology (2012) 1.26
A role for pectin de-methylesterification in a developmentally regulated growth acceleration in dark-grown Arabidopsis hypocotyls. New Phytol (2010) 1.23
Effects of ranibizumab in patients with subfoveal choroidal neovascularization attributable to age-related macular degeneration. Am J Ophthalmol (2009) 1.23
Decreased visual function after patchy loss of retinal pigment epithelium induced by low-dose sodium iodate. Invest Ophthalmol Vis Sci (2009) 1.20
Changes in fundus autofluorescence in patients with age-related maculopathy. Correlation to visual function: a prospective study. Graefes Arch Clin Exp Ophthalmol (2004) 1.17
The effects of a flexible visual acuity-driven ranibizumab treatment regimen in age-related macular degeneration: outcomes of a drug and disease model. Invest Ophthalmol Vis Sci (2009) 1.15
Behavior of SD-OCT-detected hyperreflective foci in the retina of anti-VEGF-treated patients with diabetic macular edema. Invest Ophthalmol Vis Sci (2012) 1.07
Consensus structure elucidation combining GC/EI-MS, structure generation, and calculated properties. Anal Chem (2012) 1.03
Predictors of short-term visual outcome after anti-VEGF therapy of macular edema due to central retinal vein occlusion. Invest Ophthalmol Vis Sci (2011) 1.03
[Treatment of Acute Central Retinal Artery Occlusion (CRAO) by Hyperbaric Oxygenation Therapy (HBO)--Pilot study with 21 patients]. Klin Monbl Augenheilkd (2002) 1.03
The glucocorticoid triamcinolone acetonide inhibits osmotic swelling of retinal glial cells via stimulation of endogenous adenosine signaling. J Pharmacol Exp Ther (2005) 1.01
Proprioception in total, hemi- and reverse shoulder arthroplasty in 3D motion analyses: a prospective study. Int Orthop (2008) 1.00
A new instrument for the quantification of macular pigment density: first results in patients with AMD and healthy subjects. Graefes Arch Clin Exp Ophthalmol (2002) 0.99
Ethnic differences in macular pigment density and distribution. Invest Ophthalmol Vis Sci (2007) 0.97
Distribution of amyloid precursor protein and amyloid-beta immunoreactivity in DBA/2J glaucomatous mouse retinas. Invest Ophthalmol Vis Sci (2007) 0.96
Fixation stability and macular light sensitivity in patients with diabetic maculopathy: a microperimetric study with a scanning laser ophthalmoscope. Ophthalmologica (2005) 0.96
Selective staining by vital dyes of Müller glial cells in retinal wholemounts. Glia (2004) 0.94
Different antivascular endothelial growth factor treatments and regimens and their outcomes in neovascular age-related macular degeneration: a literature review. Br J Ophthalmol (2013) 0.92
p16 expression differentiates high-risk gastrointestinal stromal tumor and predicts poor outcome. Neoplasia (2008) 0.92
Small dense particles in the retina observable by spectral-domain optical coherence tomography in age-related macular degeneration. Invest Ophthalmol Vis Sci (2010) 0.92
Blue-light versus green-light autofluorescence: lesion size of areas of geographic atrophy. Invest Ophthalmol Vis Sci (2011) 0.91
Database supported candidate search for metabolite identification. J Integr Bioinform (2011) 0.91
Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF. Mol Vis (2005) 0.91
Extracellular invertase is involved in the regulation of clubroot disease in Arabidopsis thaliana. Mol Plant Pathol (2010) 0.90
Long-term intraocular pressure changes in patients with neovascular age-related macular degeneration treated with ranibizumab. Ophthalmologica (2013) 0.89
External application of gametophyte-specific ZmPMEI1 induces pollen tube burst in maize. Plant Reprod (2013) 0.88
Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment study (SPR Study): recruitment list evaluation. Study report no. 2. Graefes Arch Clin Exp Ophthalmol (2006) 0.88
Angiographic findings in patients with exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2002) 0.88
Macular pigment density in age-related maculopathy. Graefes Arch Clin Exp Ophthalmol (2004) 0.86
Association of macular pigment density with plasma ω-3 fatty acids: the PIMAVOSA study. Invest Ophthalmol Vis Sci (2012) 0.86
Intraocular pressure changes following 20G pars-plana vitrectomy. Acta Ophthalmol (2011) 0.86
Impact of optic media opacities and image compression on quantitative analysis of optical coherence tomography. Invest Ophthalmol Vis Sci (2008) 0.85
Expression of HB-EGF by retinal pigment epithelial cells in vitreoretinal proliferative disease. Curr Eye Res (2006) 0.85
Progression of age-related geographic atrophy: role of the fellow eye. Invest Ophthalmol Vis Sci (2011) 0.84
Diversity of aquaporin mRNA expressed by rat and human retinas. Neuroreport (2005) 0.84
Treatment of branch retinal vein occlusion induced macular edema with bevacizumab. BMC Ophthalmol (2008) 0.83
Complement Factor P in choroidal neovascular membranes of patients with age-related macular degeneration. Retina (2009) 0.82
Relevance of wide-field autofluorescence imaging in Birdshot retinochoroidopathy: descriptive analysis of 76 eyes. Acta Ophthalmol (2013) 0.82
Identification of P2Y receptor subtypes in human muller glial cells by physiology, single cell RT-PCR, and immunohistochemistry. Invest Ophthalmol Vis Sci (2005) 0.82
Simple and objective method for routine detection of the macular pigment xanthophyll. J Biomed Opt (2011) 0.81
Quantitative assessment of the long-term effect of photodynamic therapy in patients with pathologic myopia. Graefes Arch Clin Exp Ophthalmol (2005) 0.81
Can shoulder arthroplasty restore the range of motion in activities of daily living? A prospective 3D video motion analysis study. J Shoulder Elbow Surg (2010) 0.80
Three-year results of visual outcome with disease activity-guided ranibizumab algorithm for the treatment of exudative age-related macular degeneration. Acta Ophthalmol (2012) 0.80
Fluorescence lifetime imaging in retinal artery occlusion. Invest Ophthalmol Vis Sci (2015) 0.80
Macular pigment density at the site of altered fundus autofluorescence. Graefes Arch Clin Exp Ophthalmol (2010) 0.79
Results of high-density silicone oil as a tamponade agent in macular hole retinal detachment in patients with high myopia. Br J Ophthalmol (2007) 0.79
Complications after photodynamic therapy. Arch Ophthalmol (2005) 0.79
Effects of combination therapy with verteporfin photodynamic therapy and ranibizumab in patients with age-related macular degeneration. Acta Ophthalmol (2009) 0.79
RETINAL LAYER RESPONSE TO RANIBIZUMAB DURING TREATMENT OF DIABETIC MACULAR EDEMA: Thinner is Not Always Better. Retina (2016) 0.79
Oral Lutein Supplementation Enhances Macular Pigment Density and Contrast Sensitivity but Not in Combination With Polyunsaturated Fatty Acids. Invest Ophthalmol Vis Sci (2015) 0.79
Macular pigment measurements: which method should we use? Graefes Arch Clin Exp Ophthalmol (2006) 0.78
Three-dimensional motion analysis of compensatory movements in patients with radioulnar synostosis performing activities of daily living. J Orthop Sci (2009) 0.78
Increased upconversion quantum yield in photonic structures due to local field enhancement and modification of the local density of states--a simulation-based analysis. Opt Express (2013) 0.78
Glial cell expression of hepatocyte growth factor in vitreoretinal proliferative disease. Lab Invest (2004) 0.78
Detection of Chlamydia and complement factors in neovascular membranes of patients with age-related macular degeneration. Ocul Immunol Inflamm (2013) 0.78
Spectral-domain optical coherence tomography findings after severe exogenous endophthalmitis. Ocul Immunol Inflamm (2014) 0.77
Fluctuations in Pigment Epithelial Detachment and Retinal Fluid Using a Bimonthly Treatment Regimen with Aflibercept for Neovascular Age-Related Macular Degeneration. Ophthalmologica (2015) 0.77
Multimodal imaging in macular diagnostics: combined OCT-SLO improves therapeutical monitoring. Graefes Arch Clin Exp Ophthalmol (2007) 0.77
Physiological properties of retinal Muller glial cells from the cynomolgus monkey, Macaca fascicularis--a comparison to human Muller cells. Vision Res (2005) 0.77
Strabological results in patients with macular translocation surgery and counterrotation of the globe as a secondary procedure. Strabismus (2002) 0.76
Age-related decrease of potassium currents in glial (Müller) cells of the human retina. Can J Ophthalmol (2003) 0.76
VISUAL ACUITY OUTCOMES OF RANIBIZUMAB TREATMENT IN PATHOLOGIC MYOPIC EYES WITH MACULAR RETINOSCHISIS AND CHOROIDAL NEOVASCULARIZATION. Retina (2017) 0.75
Patch-clamp recording of Müller glial cells after cryopreservation. J Neurosci Methods (2002) 0.75
Foraging on the potential energy surface: a swarm intelligence-based optimizer for molecular geometry. J Chem Phys (2012) 0.75
Macular edema: miscellaneous. Eur J Ophthalmol (2011) 0.75
Autofluorescence Lifetimes in Geographic Atrophy in Patients With Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci (2016) 0.75
CONIFER - Non-Interventional Study to Evaluate Therapy Monitoring During Deferasirox Treatment of Iron Toxicity in Myelodysplastic Syndrome Patients with Transfusional Iron Overload. Oncol Res Treat (2016) 0.75
FUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY. Retina (2017) 0.75
The Presence of Intra- or Subretinal Fluid during the Loading Phase in the Treatment of Exudative Age-Related Macular Degeneration with Intravitreal Ranibizumab Assessed by Optical Coherence Tomography. Ophthalmologica (2015) 0.75
Femoral derotation. J Pediatr Orthop (2006) 0.75
Macular edema. Miscellaneous. Dev Ophthalmol (2010) 0.75
Reply to the Letter by Kaya Entitled 'Fluctuation Speed as a New Criterion to Evaluate the Efficiency of Intravitreal Anti-VEGF Drugs'. Ophthalmologica (2016) 0.75
The new Editor-in-Chief of Ophthalmologica. Ophthalmologica (2014) 0.75
Senile scleral plaques imaged with enhanced depth optical coherence tomography. Acta Ophthalmol (2014) 0.75
Chorioretinal nocardiosis. Retin Cases Brief Rep (2009) 0.75
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES OF TORPEDO MACULOPATHY. Retin Cases Brief Rep (2017) 0.75
Upconversion-enabled array spectrometer for the mid-infrared, featuring kilohertz spectra acquisition rates. Opt Express (2017) 0.75
Comparison of 55° Wide-Field Spectral Domain Optical Coherence Tomography and Conventional 30° Optical Coherence Tomography for the Assessment of Diabetic Macular Edema. Ophthalmologica (2017) 0.75
Outcomes when Switching from a pro re nata Regimen to a Treat and Extend Regimen Using Aflibercept in Neovascular Age-Related Macular Degeneration. Ophthalmologica (2016) 0.75
Oligomerization in endoplasmic reticulum stress signaling. Prog Mol Biol Transl Sci (2013) 0.75
Retinal complications after damaging the vitreolenticular barrier. Ophthalmologica (2011) 0.75
Self-gated mid-infrared short pulse upconversion detection for gas sensing. Opt Express (2017) 0.75